ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
ag真人平台官方:About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
Leadership Team
ag真人平台官方:Scientific Advisory Board
ag真人平台官方:Our Businesses
Heparin Business
ag真人平台官方:Global Industrial Chain
ag真人平台官方:Global Heparin Injections Business
Product Profile
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
Company News
ag真人平台官方:Investor Relations
ag真人平台官方:Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
ag真人平台官方:H-Share Information
ag真人平台官方:A-Share Information
H-Share Information
2022.08.30
ag真人平台官方:独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和...
2022.08.30
ag真人平台官方:半年度非经营性资金占用及其他关联资金往来情况汇总表
2022.08.30
ag真人平台官方:2022年半年度报告摘要
2022.08.30
ag真人平台官方:2022年半年度报告
2022.08.29
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
2022.08.15
DATE OF BOARD MEETING
2022.07.21
ag真人平台官方:第五届董事会第二十次会议决议公告
2022.07.21
ag真人平台官方:2021年年度权益分派实施公告
2022.07.13
POSITIVE PROFIT ALERT ANNOUNCEMENT ON THE ESTIMATED INCREASE IN PROFIT FOR THE I...
2022.07.13
ag真人平台官方:2022年半年度业绩预告
第一页
上一页
18
19
20
21
22
下一页
最后一页
About Hepalink
ag真人平台官方:Group Profile
ag真人平台官方:Corporate Philosophy
ag真人平台官方:Milestones
ag真人平台官方:Leadership Team
ag真人平台官方:Scientific Advisory Board
Our Businesses
Heparin Business
ag真人平台官方:CDMO Services
ag真人平台官方:Innovative Drugs
ag真人平台官方:Global Manufacturing
ag真人平台官方:Company News
Investor Relations
Corporate Governance
ag真人平台官方:Disclosures
ag真人平台官方:Stock Information
ag真人平台官方:IR Events
ag真人平台官方:IR Contact
Join Us
ag真人平台官方:Career Development
ag真人平台官方:Contact Us
Official WeChat Account
Legal Statement
·
ag真人平台官方:Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.